1. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
   Zuhua Chen et al, 2018, J Hematol Oncol CrossRef
2. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling
   Joseph Tintelnot et al, 2020, Front. Oncol. CrossRef
3. Partial agonistic effect of cetuximab on epidermal growth factor receptor and Src kinase activation in triple‑negative breast cancer cell lines
   Hakan Gurdal et al, 2019, Int J Oncol CrossRef
4. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
   Javier Vaquero et al, 2018, Clin Cancer Res CrossRef
5. IGF-I Induces Epithelial-to-Mesenchymal Transition via the IGF-IR‐Src‐MicroRNA-30a‐E-Cadherin Pathway in Nasopharyngeal Carcinoma Cells
   Ruoyu Wang et al, 2016, oncol res CrossRef
6. c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial–mesenchymal transition
   SunYoung Lee et al, 2022, Exp Biol Med (Maywood) CrossRef
7. Feature selection translates drug response predictors from cell lines to patients
   Shinsheng Yuan et al, 2023, Front. Genet. CrossRef